TITweetIndex

JAMA Neurology @JAMANeuro · 26 Aug 2026

In 2 clinical trials, once-daily #tevapadon improved symptoms in patients with #ParkinsonDisease, increasing daily good on time in those taking levodopa and improving motor scores in early disease vs placebo. 📖 Read the full article to learn more: https://t.co/cQzOihIPBD https://t.co/Pp8wD61inC
3 913Views
51Likes
14Reposts
1Replies
0Quotes
25Bookmarks

Is that a lot?

1.51×vs this author's median2 597 views is typical
80Percentile for this authorof 5 recent posts
1.43×vs 10K–100K median2 743 views is typical
5.80%Reachviews ÷ followers
1.69%Engagement rateof viewers reacted

Compare with the benchmark table →

Open on X →